# ISORX CYCLOTRON CENTER – FDA Inspection, Mar 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/isorx-cyclotron-center/af840374-ff22-415a-84c2-98e6b3dddedd
Source feed: FDA_Inspections

> FDA inspection 1307106 of ISORX CYCLOTRON CENTER, March 13, 2026. 7 citations under 21 CFR part 212. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307106
- Company Name: ISORX CYCLOTRON CENTER
- Inspection Date: 2026-03-13
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 7

## Related Documents

- [FDA Inspection 1264258 - 2025-03-20](https://www.keypedia.com/records/fda_inspections/isorx-cyclotron-center/acb95493-b2ab-4b18-a36c-ed6168464e55)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [FDA Associated Person](https://www.keypedia.com/people/ronda-r-lloyd-jones/1446ba41-f1f2-4d40-8902-021b2bef3a53)
- [Issuing Officer](https://www.keypedia.com/people/ronda-r-loyd-jones/b10f3112-6439-4182-855f-f1be491d1f39)

Company: https://www.keypedia.com/companies/isorx-cyclotron-center/a96b7742-c699-4b8b-ab67-9bf281830698

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
